CHARACTERIZATION OF MURINE AND HUMAN IG-D-RECEPTORS ON T
小鼠和人类 IG-D-受体在 T 上的表征
基本信息
- 批准号:3453615
- 负责人:
- 金额:$ 11.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-02-01 至 1994-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Previous observations have established the rapid upregulation by oligomeric
or cross-linked, but not monomeric, IgD of receptors for IgD (IgD-R) on a
large percentage of murine and human peripheral T cells and helper T cell
clones. IgD-R on T cells are also induced by stimulation with anti-CD3,
IL-2, IL-4, IFN-gamma, and alternate pathway stimulating agents, such as
PMA + ionophore. Many of these reagents, except for IL-2 and alternate
pathway stimulators, fail to upregulate IgD-R on T cells from aged mice.
In view of the immunoaugmenting properties of IgD-R+ T cells in young, but
not in aged mice, these IgD-R appear to stabilize/promote T-B cell
interaction, particularly with B cells bearing cross-linked surface IgD.
Murine and human helper T hybridoma cells also express IgD-R and release
soluble binding factors for IgD (IgD-BF) into their supernatants under the
influence of IL-2, IL-4 or crosslinked IgD. Murine IgD-R+ receptors are
40kD molecules that can be specifically precipitated by IgD-Sepharose.
These molecules, as well as isolated human IgD-R will be purified and
subjected to partial amino acid sequencing. The numbers of IgD-R per cell
will be quantitated on normal T cells, IgD-treated T cells and T hybridoma
cells. Antibodies to the human IgD-R/BF (LTB9) are available and
antibodies to the murine IgD-R/BF are being evaluated for specificity.
Cloning of the cDNA of the human and murine IgD-R/BF will be approached
using available activated T-cell cDNA libraries. Additional studies will
concern the fine specificity of both the murine and human IgD-R: In view
of recent findings implicating N-glycans on IgD in its binding to the
murine IgD-R, the functional role of these glycans will be investigated.
Particular attention will be given to the role of carbohydrate determinants
on human IgD in its binding to the human T cell IgD-R.
先前的观察已经确定了低聚物的快速上调
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ASHOK R AMIN其他文献
ASHOK R AMIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ASHOK R AMIN', 18)}}的其他基金
Tissue Bank for Surgical Samples & Blood Cells from Patients with Osteoarthritis
手术样本组织库
- 批准号:
6974310 - 财政年份:2004
- 资助金额:
$ 11.67万 - 项目类别:
CHARACTERIZATION OF MURINE AND HUMAN IG-D-RECEPTORS ON T
小鼠和人类 IG-D-受体在 T 上的表征
- 批准号:
3453614 - 财政年份:1992
- 资助金额:
$ 11.67万 - 项目类别:
相似海外基金
Study on the mechanism of prolonged half-life of blood IgY by unique antibody receptor and its application to immune enhancement in birds
独特抗体受体延长血液IgY半衰期的机制研究及其在禽类免疫增强中的应用
- 批准号:
23H02361 - 财政年份:2023
- 资助金额:
$ 11.67万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Innate immune functions of the intracellular antibody receptor TRIM21
细胞内抗体受体 TRIM21 的先天免疫功能
- 批准号:
nhmrc : GNT1124162 - 财政年份:2017
- 资助金额:
$ 11.67万 - 项目类别:
Early Career Fellowships
Innate immune functions of the intracellular antibody receptor TRIM21
细胞内抗体受体 TRIM21 的先天免疫功能
- 批准号:
nhmrc : 1124162 - 财政年份:2017
- 资助金额:
$ 11.67万 - 项目类别:
Early Career Fellowships
Mechanism and engineering of IgG-based monoclonal antibody/receptor interactions
基于 IgG 的单克隆抗体/受体相互作用的机制和工程
- 批准号:
9300976 - 财政年份:2015
- 资助金额:
$ 11.67万 - 项目类别:
Mechanism and engineering of IgG-based monoclonal antibody/receptor interactions
基于 IgG 的单克隆抗体/受体相互作用的机制和工程
- 批准号:
9920805 - 财政年份:2015
- 资助金额:
$ 11.67万 - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8900121 - 财政年份:2012
- 资助金额:
$ 11.67万 - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8225814 - 财政年份:2012
- 资助金额:
$ 11.67万 - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8699511 - 财政年份:2012
- 资助金额:
$ 11.67万 - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8525355 - 财政年份:2012
- 资助金额:
$ 11.67万 - 项目类别:
Small Grants for Exploratory Research: Separation of Cells and Biological Macromolecules by Antibody Receptor Coated Magnetic Vesicles and Ferritin Conjugates
探索性研究小额资助:通过抗体受体包被的磁囊和铁蛋白缀合物分离细胞和生物大分子
- 批准号:
9115537 - 财政年份:1991
- 资助金额:
$ 11.67万 - 项目类别:
Standard Grant